ELKHART, Ind. -- (Business Wire)
CTS Corporation (NYSE: CTS) a leading supplier of electronics
manufacturing services, today announced that CTS EMS has been awarded a
second production program to provide printed circuit board assemblies
for a leading global medical orthopedic firm.
CTS EMS will provide assemblies used in a new orthopedic surgical
application. These assemblies will be manufactured in CTS’ New Hampshire
facility with shipments beginning in the first quarter 2013. CTS is
currently in production for high-volume surgical instrumentation,
including printed circuit assemblies, testing, certification and final
assembly in a clean room environment as a result of the first production
award secured from this major medical orthopedic firm in 2011. Annual
revenues from both programs are expected to be approximately $10 million.
This business win is a direct result of CTS’ success in producing FDA
approved medical instruments.
About CTS EMS
CTS EMS is a turnkey provider of manufacturing
solutions to customers in a range of electronics equipment markets. With
global manufacturing facilities in North America, Europe and Asia, a
broad product offering and a complete range of turnkey services, CTS is
the ideal choice for an OEM seeking customized product solutions from a
focused and agile EMS partner.
CTS is a leading designer and manufacturer of
electronic components and sensors and a provider of electronics
manufacturing services (EMS) to OEMs in the automotive, communications,
medical, defense and aerospace, industrial and computer markets. CTS
manufactures products in North America, Europe and Asia. CTS' stock is
traded on the NYSE under the ticker symbol "CTS.” To find out more,
visit the CTS Web site at www.ctscorp.com.
Safe Harbor Statement
This press release contains statements
that are, or may be deemed to be, forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements include, but are not limited to, any
financial or other guidance, statements that reflect our current
expectations concerning future results and events and any other
statements that are not based solely on historical fact. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof and are based on
various assumptions as to future events, the occurrence of which
necessarily are subject to uncertainties. These forward-looking
statements are made subject to risks, uncertainties and other factors,
which could cause our actual results, performance or achievements to
differ materially from those presented in the forward-looking
statements, including, without limitation: changes in the economy
generally and in respect to the businesses in which CTS operates;
unanticipated issues in integrating acquisitions; rapid technological
change; general market conditions in the automotive, communications and
computer industries, as well as conditions in the industrial, defense
and aerospace and medical markets; reliance on key customers;
unanticipated natural or other events such as the Japan earthquake and
floods in Thailand; the ability to protect our intellectual property;
pricing pressures and demand for our products; and risks associated with
our international operations, including trade and tariff barriers,
exchange rates and political and geographical risks. For more detailed
information on the risks and uncertainties associated with CTS’
business, see the reports CTS files with the Securities and Exchange
Commission available at http://www.ctscorp.com/investor_relations/investor.htm.
CTS undertakes no obligation to publicly update its forward-looking
statements to reflect new information or events or circumstances that
arise after the date hereof, including market or industry changes.
Thomas A. Kroll, Vice President and Chief Financial
Mitchell J. Walorski, Director of
Investor Relations, 574-523-3800
Source: CTS Corporation
© 2016 Canjex Publishing Ltd. All rights reserved.